Biological Aging Measures Based on Blood DNA Methylation and Risk of Cancer: A Prospective Study.
Pierre-Antoine DuguéJulie K BassettEe Ming WongJiHoon E JooSherly X LiChenglong YuDaniel F SchmidtEnes MakalicNicole Wong DooDaniel D BuchananAllison M HodgeDallas R EnglishJohn L HopperGraham G GilesMelissa C SoutheyRoger L MilnePublished in: JNCI cancer spectrum (2020)
The methylation-based measures PhenoAge and GrimAge may provide insights into the relationship between biological aging and cancer and be useful to predict cancer risk, particularly for lung cancer.